Cargando…

Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19

Detalles Bibliográficos
Autores principales:	Martín-Vicente, María, Berenguer, Juan, Muñoz-Gómez, María José, Díez, Cristina, Micán, Rafael, Pérez-Elías, María Jesús, García-Fraile, Lucio Jesús, Peraire, Joaquin, Suárez-García, Inés, Jiménez-Sousa, María Ángeles, Fernández-Rodríguez, Amanda, Vázquez, Mónica, Ryan, Pablo, González-García, Juan, Jarrín, Inmaculada, Mas, Vicente, Martínez, Isidoro, Resino, Salvador
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574204/ https://www.ncbi.nlm.nih.gov/pubmed/34752819 http://dx.doi.org/10.1016/j.jinf.2021.11.002

Ejemplares similares

Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort
por: Berenguer, Juan, et al.
Publicado: (2021)

COVID‐19 in hospitalized HIV‐positive and HIV‐negative patients: A matched study
por: Díez, Cristina, et al.
Publicado: (2021)

DBP rs7041 and DHCR7 rs3829251 are Linked to CD4(+) Recovery in HIV Patients on Antiretroviral Therapy
por: Resino, Salvador, et al.
Publicado: (2022)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

Successful HCV Therapy Reduces Liver Disease Severity and Inflammation Biomarkers in HIV/HCV-Coinfected Patients With Advanced Cirrhosis: A Cohort Study
por: Medrano, Luz Maria, et al.
Publicado: (2021)

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
por: Brochado, Óscar, et al.
Publicado: (2021)

Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients
por: Medrano, Luz M., et al.
Publicado: (2016)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals (†)
por: Molina-Carrión, Silvia, et al.
Publicado: (2020)

Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
por: Portocarrero Nuñez, Julian Alexander, et al.
Publicado: (2018)

Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice
por: Suárez-García, Inés, et al.
Publicado: (2023)

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
por: Vigón, Lorena, et al.
Publicado: (2019)

FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients
por: Pineda-Tenor, Daniel, et al.
Publicado: (2014)

Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status
por: Garcia-Broncano, Pilar, et al.
Publicado: (2018)

TRIM25 in the Regulation of the Antiviral Innate Immunity
por: Martín-Vicente, María, et al.
Publicado: (2017)

PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional study
por: García-Broncano, Pilar, et al.
Publicado: (2014)

siRNA-Mediated Simultaneous Regulation of the Cellular Innate Immune Response and Human Respiratory Syncytial Virus Replication
por: Martín-Vicente, María, et al.
Publicado: (2019)

Early innate immune response triggered by the human respiratory syncytial virus and its regulation by ubiquitination/deubiquitination processes
por: Martín-Vicente, María, et al.
Publicado: (2022)

Mx1, OAS1 and OAS2 polymorphisms are associated with the severity of liver disease in HIV/HCV-coinfected patients: A cross-sectional study
por: García-Álvarez, Mónica, et al.
Publicado: (2017)

Association between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional study
por: Guzmán-Fulgencio, María, et al.
Publicado: (2015)

ADAR1 polymorphisms are related to severity of liver fibrosis in HIV/HCV-coinfected patients
por: Medrano, Luz M., et al.
Publicado: (2017)

HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1
por: Berenguer, Juan, et al.
Publicado: (2019)

European mitochondrial haplogroups predict liver-related outcomes in patients coinfected with HIV and HCV: a retrospective study
por: Aldámiz-Echevarría, Teresa, et al.
Publicado: (2019)

Plasma IP-10 and IL-6 are linked to Child-Pugh B cirrhosis in patients with advanced HCV-related cirrhosis: a cross-sectional study
por: Salgüero, Sergio, et al.
Publicado: (2020)

Hepatitis C virus vaccine design: focus on the humoral immune response
por: Sepulveda-Crespo, Daniel, et al.
Publicado: (2020)

Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)
por: Vázquez-Morón, Sonia, et al.
Publicado: (2019)

Validation of the attitudes towards people living with HIV/AIDS scale in nursing students
por: Gázquez-López, María, et al.
Publicado: (2023)

Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of Outcome
por: Aldámiz-Echevarría, Teresa, et al.
Publicado: (2016)

High SARS-CoV-2 Viral Load and Low CCL5 Expression Levels in the Upper Respiratory Tract Are Associated With COVID-19 Severity
por: Pérez-García, Felipe, et al.
Publicado: (2021)

Metabolic changes during respiratory syncytial virus infection of epithelial cells
por: Martín-Vicente, María, et al.
Publicado: (2020)

Production and characterization of monoclonal antibodies for the detection of the hepatitis C core antigen
por: Vidal-Alcántara, Erick Joan, et al.
Publicado: (2023)

A deficient immune response to SARS-CoV-2 in the nasopharynx is associated with severe COVID-19 pneumonia
por: Pita-Martínez, Carlos, et al.
Publicado: (2023)

IL7RA rs6897932 Polymorphism Is Associated with Better CD4(+) T-Cell Recovery in HIV Infected Patients Starting Combination Antiretroviral Therapy
por: Resino, Salvador, et al.
Publicado: (2019)

Trends in HIV prevalence among young people in generalised epidemics: implications for monitoring the HIV epidemic
por: Mahy, Mary, et al.
Publicado: (2012)

HIV surveillance in MENA: recent developments and results
por: Bozicevic, Ivana, et al.
Publicado: (2013)

Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019
por: Fanciulli, Chiara, et al.
Publicado: (2022)

Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV
por: Teira, Ramón, et al.
Publicado: (2021)

Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
por: Berenguer, Juan, et al.
Publicado: (2020)

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
por: Rodríguez-Baño, Jesús, et al.
Publicado: (2021)

HIV and STI Prevention Among Spanish Women Who have Sex with Women: Factors Associated with Dental Dam and Condom Use
por: Gil-Llario, María Dolores, et al.
Publicado: (2022)

Downregulation of A20 Expression Increases the Immune Response and Apoptosis and Reduces Virus Production in Cells Infected by the Human Respiratory Syncytial Virus
por: Martín-Vicente, María, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6823516e3qo6a5sc8eeqcvik7v